# Bimergen Energy Corp: Form 10-Q for the period ended Sep 30, 2020

- Company: [Bimergen Energy Corp](/companies/bess.md) (CIK 1066764)
- Form: 10-Q
- Filed: 2020-11-13
- Accepted by EDGAR: Nov 13, 2020, 21:06 ET
- Period: 2020-09-30
- Accession: 0001185185-20-001575
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1066764/000118518520001575/spineinj20200930_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1066764/000118518520001575/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-07-01 to 2020-09-30 | $47.1k | us-gaap:Revenues |
| Revenue | 9 months, 2020-01-01 to 2020-09-30 | $156.4k | us-gaap:Revenues |
| Cost of revenue | 3 months, 2020-07-01 to 2020-09-30 | $0 | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2020-01-01 to 2020-09-30 | $0 | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2020-07-01 to 2020-09-30 | $47.1k | us-gaap:GrossProfit |
| Gross profit | 9 months, 2020-01-01 to 2020-09-30 | $156.4k | us-gaap:GrossProfit |
| Operating income | 3 months, 2020-07-01 to 2020-09-30 | −$74.8k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2020-01-01 to 2020-09-30 | −$229.3k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2020-07-01 to 2020-09-30 | $5.6k | us-gaap:InterestExpense |
| Interest expense | 9 months, 2020-01-01 to 2020-09-30 | $18.4k | us-gaap:InterestExpense |
| Net income | 3 months, 2020-07-01 to 2020-09-30 | −$80.4k | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2020-01-01 to 2020-09-30 | −$247.2k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-07-01 to 2020-09-30 | $0.00 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months, 2020-01-01 to 2020-09-30 | −$0.01 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months, 2020-01-01 to 2020-09-30 | $406.6k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2020-09-30 | $56.3k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-09-30 | $338.7k | us-gaap:AssetsCurrent |
| Total assets | at 2020-09-30 | $420.0k | us-gaap:Assets |
| Current liabilities | at 2020-09-30 | $593.3k | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-09-30 | $618.2k | us-gaap:Liabilities |
| Current portion of debt | at 2020-09-30 | $39.2k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2020-09-30 | −$198.3k | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 10,134 characters.

The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes to the financial statements included in this Form 10-Q.

### Critical Accounting Policies

See Note 3 of the accompanying notes to unaudited condensed consolidated financial statements, which note is incorporated herein by reference.

### Management Overview

During the fourth quarter of 2018, the decision was made to discontinue involvement in future medical procedures due to our cash position, which also hampers our ability to pay back existing debt to Wells Fargo. We did not perform any procedures in 2020 thus far or in 2019 and will not do so unless we can access additional capital. The service revenue we have earned has resulted in longer settlement times, which has created a slowdown in cash collections. Additionally, despite our efforts to establish a market for the Quad Video Halo, such market has not met our expectations and we have cut back its development and operations.

Moving forward, our main focus will be collecting accounts receivable, paying down debt and leveraging our position as a fully reporting public company for other investing opportunities.

There can be no guarantee of us continuing as a going concern if we cannot obtain additional funds.

We are actively pursuing a merger with a private company where they become the controlling company. We find this to be the best course of action for our stockholders.

Additionally, the COVID-19 pandemic has made it difficult for us to collect our accounts receivable, as attorney and medical offices are closed resulting in delayed settlements and medical procedures being canceled, which affects our lease revenue. We are uncertain how this pandemic will affect our ability to collect in the future or its overall effect on our lease revenue.

On August 21, 2020, Jeffrey A. Cronk, D.C., a member of our board of directors, notified us that he was resigning from the board for personal reasons, effective August 31, 2020. Dr. Cronk confirmed that his resignation was not because of any disagreement with us on any matter relating to our operations, policies or practices.

### Results of Operations

The unaudited financial statements for the nine months ended September 30, 2020 and 2019 have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with instructions to Form 10-Q. In the opinion of management, the unaudited condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the financial position as of September 30, 2020 and the results of operations and cash flows for the three and nine months ended September 30, 2020 and 2019. The results for the three and nine months ended September 30, 2020 is not necessarily indicative of the results to be expected for the entire year ending December 31, 2020 or any subsequent period.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to the Securities and Exchange Commission’s rules and regulations. These unaudited financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended December 31, 2019 as included in our previously filed report on Form 10-K.

***Comparison of the three-month period ended September 30, 2020 with the three month-period ended September 30, 2019.***

The revenue for the three months ended September 30, 2020 of $47,139 consisted of $25,573 of QVH leasing revenue, and $21,566 related to excess collections for previously performed procedures. The revenue for the three months ended September 30, 2019 of $82,972 consisted of $24,973 of QVH leasing revenue, and $57,999 related to excess collections for previously performed procedures.

During the three months ended September 30, 2020, we incurred $121,908 of operating, general and administrative expenses compared to $495,477 for the same period in 2019, coupled with an impairment of goodwill charge of $170,200 during the 2019 period. Operating, general and administrative expenses were lower for the 2020 quarter compared to 2019 primarily because of decreases in payroll expenses of $19,146, depreciation expense of $13,707, factoring expense of $71,192, and bad debt expense net of recoveries of $266,120.

As a result of the foregoing, we had net loss of $80,393 for the three months ended September 30, 2020, compared to a net loss of $687,328 for the three months ended September 30, 2019.

***Comparison of the nine-month period ended September 30, 2020 with the nine-month period ended September 30, 2019.***

The revenue for the nine months ended September 30, 2020 of $156,383 consisted of $69,368 of QVH leasing revenue, and $87,015 related to excess collections for previously performed procedures. For the same period in 2019, revenue was $150,672, consisting of $49,032 of QVH leasing and $101,640 related to excess collections for previously performed procedures.

Service cost for the nine months ended September 30, 2019 was $115,235, which consisted of inventory obsolescence write downs for the period, while there were no service costs in 2020.

During the nine months ended September 30, 2020, we incurred $385,642 of operating, general and administrative expenses compared to $1,092,678 for the same period in 2019. The decrease is attributable to decreases in payroll expenses of $66,906, consulting expense of $106,133, legal fees of $7,754, bad debt expense net of recoveries of $347,677, depreciation expense of $37,533, computer expenses of $18,977, rent expenses of $22,183, factoring expenses of $71,193, investor relations expense of $25,682 and other miscellaneous expenses of approximately $25,000.

As a result of the foregoing, we had a net loss of $247,239 for the nine months ended September 30, 2020, compared to a net loss of $1,279,148 for the nine months ended September 30, 2019.

### Liquidity and Capital Resources

For the nine months ended September 30, 2020, cash provided in operations was $406,631 which primarily included decreases in accounts receivable of $650,514, decreases in prepaid expenses of $12,314, and decreases in accounts payable and accrued liabilities of $32,096, along with non-cash operating expenses totaling $23,138. For the nine months ended September 30, 2019, cash provided in operations was $478,698 which primarily included decreases in accounts receivable of $1,053,110, decrease of related party payables of $4,967, increases in prepaid expenses of $1,350, and decreases in accounts payable and accrued liabilities of $54,910, along with non-cash operating expenses totaling $765,963.

Cash used in financing activities for the nine months ended September 30, 2020 consisted of repayments on our term loan in the amount of $470,000, payments on our note payable to a shareholder of $65,000 and proceeds of $64,097 related to our Paycheck Protection Program (PPP) loan. Cash used in financing activities for the nine months ended September 30, 2019 consisted of payments on our notes payable in the amount of $90,000 and payments on our term loan of $259,000.

#### Going Concern Considerations

Since our inception in 1998, until commencement of our spine injury diagnostic operations in August 2009, our expenses substantially exceeded our revenue, resulting in continuing losses and an accumulated deficit from operations of $15,004,698 as of December 31, 2009. Since that time, our accumulated deficit has increased $5,083,329 to $20,088,027 as of September 30, 2020. During the nine months ended September 30, 2020, we realized net revenue of $156,383 and incurred a net loss of $247,239. Successful business operations and our ability to generate cash flows from operations, sufficient to meet our debt obligations are dependent upon obtaining additional financing and achieving a level of collections adequate to support our cost structure. Considering the nature of our business, we are not generating immediate liquidity and sufficient working capital within a reasonable period of time to fund our planned operations and strategic business plan for a period of one year from the filing of this report. There can be no assurances that there will be adequate financing available to us.

Additionally, during the fourth quarter of 2018, the decision was made to discontinue involvement in future medical procedures due to our cash position, which also hampers our ability to pay back existing debt to our shareholder (see Note 6—Term Loan and Notes Payable). We were not involved with any procedures in 2020 or 2019 and will not do so unless we can access additional capital. The service revenue we have earned has resulted in longer settlement times, which has created a slowdown in cash collections. Additionally, despite our efforts to establish a market for the Quad Video Halo, such market has not met our expectations and we have cut back its development and operations. If we are unable to access additional capital in the near future, these recent developments could have a material negative impact on our financial performance and could have a material adverse effect on our results of operations and financial condition. The accompanying unaudited condensed consolidated financial statements have been prepared assuming that we will continue as a going concern. This basis of accounting contemplates the recovery of our assets and the satisfaction of liabilities in the normal course of business. The unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.

## Controls and procedures

As filed, 2,441 characters.

Our principal executive officer and principal financial officer are responsible for establishing and maintaining our disclosure controls and procedures. Such officers have concluded (based upon their evaluation of these controls and procedures as of the end of the period covered by this report) that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in this report is accumulated and communicated to management, including our principal executive and principal financial officer as appropriate, to allow timely decisions regarding required disclosure.

Our principal executive officer and principal financial officer have also indicated that, upon evaluation, there were no changes in our internal control over financial reporting or other factors during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. In addition, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Because of these inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

## Risk factors

As filed, 3,987 characters.

In addition to the other information set forth in this report, one should carefully consider the discussion of various risks and uncertainties contained in Part I, Item 1A, “Risk Factors” in our 2019 Annual Report on Form 10-K. We believe the risk factors presented in this filing and those presented on our 2019 Form 10-K are the most relevant to our business and could cause our results to differ materially from any forward-looking statements made by us.

***The COVID-19 pandemic has had, and is expected to continue to have, an adverse impact on our business, results of operations and financial condition, and other pandemics, epidemics or disease outbreaks could have a similar impact. The extent to which COVID-19 impacts our business will depend on future developments, which are highly uncertain and cannot be predicted.***

The recent outbreak of COVID-19, which has been declared by the World Health Organization to be a pandemic, has spread across the globe and is impacting worldwide economic activity. The outbreak has resulted in authorities implementing numerous measures to try to contain the virus, such as travel bans and restrictions, social distancing guidelines, quarantines, shelter in place orders and business shutdowns. These measures have not only negatively impacted consumer spending and business spending habits, they have also adversely impacted and may further impact our workforce and operations and the operations of our customers, suppliers and business partners. The duration of these measures is unknown and may be extended, and additional measures may be imposed. This will likely continue to adversely affect our business, results of operations and financial condition.

The COVID-19 pandemic has made it difficult for us to collect our accounts receivable, as attorney and medical offices are closed resulting in delayed settlements and medical procedures being canceled, which affects our lease revenue. We are uncertain how this pandemic will affect our ability to collect in the future or its overall effect on our lease revenue.

Further, COVID-19 has caused us to modify our business practices, including restricting employee travel, modifying employee work locations, increasing reliance on remote access to our information systems, implementing social distancing and enhanced sanitary measures in our offices. We may take further actions as may be required by government authorities or that we determine are in the best interests of our employees, customers and business partners. There is no certainty that such measures will be sufficient to mitigate the risks posed by the virus or otherwise be satisfactory to government authorities. Further, our enhanced reliance on remote access to our information systems increases our exposure to cybersecurity attacks or data security incidents.

COVID-19 has had, and is expected to continue to have, an adverse impact on our business, results of operations and financial condition. The extent to which the COVID-19 outbreak impacts our business, results of operations and financial condition will depend on future developments, which are highly uncertain and cannot be predicted, including, but not limited to, the duration and spread of the outbreak, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume. Even after the COVID-19 outbreak has subsided, we may continue to experience materially adverse impacts to our business as a result of its global economic impact, including any economic downturn or recession that has occurred or may occur in the future. The impact of COVID-19 may also exacerbate other risks discussed in Part I, "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, any of which could have a material effect on us. This situation is changing rapidly, and additional impacts may arise that we are not aware of currently.

Filed Nov 13, 2020.
Source: SEC EDGAR, the filing index for accession 0001185185-20-001575. Last ingested by Listed: Oct 24, 2026, 15:03 ET. No prices; not investment advice.
